node positive prostate cancer
Showing 1 - 25 of >10,000
Sentinel Lymph Node Biopsy in Initially Lymph Node-positive,
Completed
- Breast Cancer
- Sentinel Lymph Node
- Test cohort
-
Fuzhou, Fujian, ChinaChuan Wang
Nov 25, 2023
Node-positive Breast Cancer Trial (Axillary Lymph Node Dissection, Axillary Reverse Mapping, Lymphaticovenous Bypass)
Not yet recruiting
- Node-positive Breast Cancer
- Axillary Lymph Node Dissection
- +2 more
- (no location specified)
Jul 28, 2023
Node-positive Breast Cancer Trial (Targeted axillary lymph node dissection)
Not yet recruiting
- Node-positive Breast Cancer
- Targeted axillary lymph node dissection
- (no location specified)
Jan 6, 2023
Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in
Recruiting
- Prostate Cancer
- +2 more
-
Milan, ItalyIEO European Institute of Oncology
Oct 24, 2022
Prostate Cancer Trial in United States (drug, device, procedure)
Recruiting
- Prostate Cancer
- Administration of IS-002
- +2 more
-
San Francisco, California
- +3 more
Jul 7, 2023
Sentinel Lymph Node Trial (sentinle lymphnode biopsy)
Not yet recruiting
- Sentinel Lymph Node
- sentinle lymphnode biopsy
- (no location specified)
Nov 11, 2023
Prostate Cancer, Lymph Node Metastases Trial in Nijmegen (Radio guided surgery (RGS) using Indium-labelled PSMA)
Active, not recruiting
- Prostate Cancer
- Lymph Node Metastases
- Radio guided surgery (RGS) using Indium-labelled PSMA
-
Nijmegen, Gelderland, Netherlands
- +1 more
Apr 27, 2022
HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)
Recruiting
- HER2 Positive Early Breast Cancer
- Docetaxel
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023
Prostate Cancer Trial in Switzerland (Radical prostatectomy (RP) followed by ePLND, Radical prostatectomy (RP) only)
Active, not recruiting
- Prostate Cancer
- Radical prostatectomy (RP) followed by ePLND
- Radical prostatectomy (RP) only
-
Aarau, Switzerland
- +10 more
Feb 24, 2022
Breast Cancer Trial in Los Angeles (Lumpectomy without sentinel node biopsy)
Recruiting
- Breast Cancer
- Lumpectomy without sentinel node biopsy
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 16, 2023
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Gastric Cancer Trial in Yixing (tirelizumab, chemo with oxaliplatin + heroda)
Recruiting
- Gastric Cancer
- tirelizumab
- chemotherapy with oxaliplatin + heroda
-
Yixing, Jiangsu, ChinaYixing People's Hospital
May 3, 2023
Prostate Cancer Trial in Amsterdam (Image-guided navigation)
Recruiting
- Prostate Cancer
- Image-guided navigation
-
Amsterdam, North Holland, NetherlandsNetherlands Cancer Institute
Oct 13, 2023
Breast Cancer, Axilla; Breast Trial (Sentinel lymph Node Biopsy)
Not yet recruiting
- Breast Cancer
- Axilla; Breast
- Sentinel lymph Node Biopsy
- (no location specified)
Sep 13, 2023
Using Magtrace and Magseed Before Chemotherapy
Not yet recruiting
- Breast Cancer
- Magtrace
-
Gothenburg, SwedenSahlgrenska University Hospital
Oct 23, 2023
Melanoma Trial in Charlottesville (Excision of clinically detected lymph node metastasis before any systemic therapy, Excision
Not yet recruiting
- Melanoma
- Excision of clinically detected lymph node metastasis before any systemic therapy
- Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy
-
Charlottesville, VirginiaCancer Center at the University of Virginia
Apr 20, 2023
Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)
Available
- Castration-Resistant Prostatic Cancer
- (no location specified)
Sep 11, 2023
Breast Cancer Trial in Ann Arbor (Ribociclib, Postoperative Radiation Therapy)
Not yet recruiting
- Breast Cancer
- Ribociclib
- Postoperative Radiation Therapy
-
Ann Arbor, MichiganUniversity of Michigan
Aug 10, 2023
Esophageal Squamous Cell Carcinoma Trial in Shantou (Tislelizumab)
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shantou, Guangdong, ChinaCancer Hospital of Shantou University Medical College
Aug 2, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (AAA617, 68Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- (no location specified)
Aug 16, 2023
Prostate Cancer Trial in Hong Kong (Hemopatch)
Completed
- Prostate Cancer
- Hemopatch
-
Hong Kong, Hong KongPrince of Wales Hospital
Jun 24, 2022
Prostatic Tumors, Tumor Metastasis Trial in Bergen, Tromsø, Trondheim (PSMA-PET, PSMA-PET/MRI, PSMA-PET/CT)
Recruiting
- Prostatic Neoplasms
- Neoplasm Metastasis
- PSMA-PET
- +2 more
-
Bergen, Norway
- +2 more
Feb 8, 2022